Clinical Trials Logo

Edema Brain clinical trials

View clinical trials related to Edema Brain.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05263167 Not yet recruiting - Edema Brain Clinical Trials

Reducing Edema After intraCerebral Hemorrhage

Start date: March 15, 2022
Phase: Phase 4
Study type: Interventional

The REACH trial is a prospective multicenter double-blind randomized placebo-controlled trial with blinded end-point adjudication. Participants are randomized (1:1) to receive either sodium aescinate or matching placebo (0.9% saline). The primary outcome is the absolute volume of PHE evaluated based on brain CT image on day 14 after ICH.